{"id":6765,"date":"2026-10-20T20:57:25","date_gmt":"2026-10-20T18:57:25","guid":{"rendered":"https:\/\/pancreasvlaanderen.be\/?page_id=6765"},"modified":"2026-10-21T08:31:27","modified_gmt":"2026-10-21T06:31:27","slug":"nieuws-item-daraxonrasib","status":"publish","type":"page","link":"https:\/\/pancreasvlaanderen.be\/index.php\/nieuws-item-daraxonrasib\/","title":{"rendered":"Nieuws item Daraxonrasib"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"6765\" class=\"elementor elementor-6765\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-ae401b0 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"ae401b0\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-5418ff3\" data-id=\"5418ff3\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-30c1ba1 elementor-align-right elementor-widget elementor-widget-button\" data-id=\"30c1ba1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/pancreasvlaanderen.be\/index.php\/nieuws\/\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Meer nieuws<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6027998 elementor-widget elementor-widget-text-editor\" data-id=\"6027998\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h4 style=\"font-size: 1.33333rem; font-style: normal;\"><span style=\"font-size: 20px; color: #800080;\"><span style=\"font-size: 20px;\"><span style=\"font-weight: bold;\">Europa geeft toestemming voor veelbelovend medicijn tegen pancreaskanker<\/span><\/span><\/span><\/h4>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-268cab4 elementor-widget elementor-widget-text-editor\" data-id=\"268cab4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Het Europees Geneesmiddelenagentschap EMA adviseert om een nieuwe behandeling van pancreaskanker goed te keuren. Als ook de Europese Commissie toestemming geeft, dan kan het snel op de markt komen.<\/p><p>Nadat het al goedkeuring kreeg in de VS, is het daraxonrasib ook goed op weg om toegelaten te worden op de Europese markt. Experts van het EMA zetten het licht alvast op groen. Gewoonlijk volgt de Europese Commissie dit advies, waarna de firma kan gaan onderhandelen met de lidstaten over prijszetting en eventueel terugbetaling. In eerste instantie zal de ontwikkelaar een aanvraag moeten indienen bij de FOD Economie. Dat kan snel gaan. De onderhandeling over terugbetaling, met het Riziv, kan meer tijd in beslag nemen.<\/p><p>\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-073fed1 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"073fed1\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-7729cd3\" data-id=\"7729cd3\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-82a0a15 elementor-widget elementor-widget-text-editor\" data-id=\"82a0a15\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"font-size: 16px;\">Oncologen en pati\u00ebntenorganisaties kijken al een tijd uit naar dit medicijn. Pancreaskanker behoort tot de moeilijkst behandelbare vormen van kanker. Elk jaar krijgen meer dan tweeduizend Belgen die boodschap te horen. Vijf jaar later is slechts 16,7 procent van hen nog in leven. Met drie pilletjes per dag verdubbelt daraxonrasib de levensverwachting.<\/span><\/p><p>De therapie richt zich op het eiwit KRAS, dat vrijwel alle gevallen van alvleesklierkanker aandrijft. De pilletjes schakelen dat eiwit uit en remmen zo de groei van de kanker. Het is voor het eerst dat dit is gelukt. Nu de code is gekraakt, hopen oncologen dat dit de deur opent naar nog doeltreffendere behandelingen. \u201cDit is de eerste uit een nieuwe klasse geneesmiddelen. Er zitten er nog in de pijplijn\u201d, zei oncoloog Timon Vandamme (UZA) eerder in deze krant.<\/p><p><span style=\"font-size: 15px; font-style: normal; font-weight: 400; color: #000000;\">Bron: GvA,\u00a0<\/span><span style=\"color: #000000; font-size: 15px; font-style: normal; font-weight: 400;\">Anton Goegebuer,<\/span><span style=\"color: #000000; font-size: 15px; font-style: normal; font-weight: 400;\">\u00a016 oktober 2026<\/span><\/p><p>\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-e1f686f\" data-id=\"e1f686f\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-330606a elementor-widget elementor-widget-image\" data-id=\"330606a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"600\" height=\"376\" src=\"https:\/\/pancreasvlaanderen.be\/wp-content\/uploads\/2026\/10\/oie_2021296NvSQvz1r.png\" class=\"attachment-large size-large wp-image-6796\" alt=\"\" srcset=\"https:\/\/pancreasvlaanderen.be\/wp-content\/uploads\/2026\/10\/oie_2021296NvSQvz1r.png 600w, https:\/\/pancreasvlaanderen.be\/wp-content\/uploads\/2026\/10\/oie_2021296NvSQvz1r-300x188.png 300w\" sizes=\"(max-width: 600px) 100vw, 600px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<div class=\"elementor-element elementor-element-554515eb elementor-widget elementor-widget-text-editor\" data-id=\"554515eb\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><em style=\"color: #222222; font-family: Arial, Helvetica, sans-serif; font-size: small; font-weight: 400;\"><span style=\"font-size: 9pt; line-height: 18px; font-family: Helvetica, sans-serif; color: #202020;\">Pancreas Vlaanderen Vzw heeft als doel u op de hoogte te brengen van mogelijke studies, maar is geen expert en kan zich niet uitspreken over de studie zelf. Bij interesse, contacteert u best rechtstreeks het onderzoeksteam.<\/span><\/em><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Meer nieuws Europa geeft toestemming voor veelbelovend medicijn tegen pancreaskanker Het Europees Geneesmiddelenagentschap EMA adviseert om een nieuwe behandeling van pancreaskanker goed te keuren. Als ook de Europese Commissie toestemming geeft, dan kan het snel op de markt komen. Nadat het al goedkeuring kreeg in de VS, is het daraxonrasib ook goed op weg om [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"full-width-container","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-6765","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/pancreasvlaanderen.be\/index.php\/wp-json\/wp\/v2\/pages\/6765","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pancreasvlaanderen.be\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/pancreasvlaanderen.be\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/pancreasvlaanderen.be\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/pancreasvlaanderen.be\/index.php\/wp-json\/wp\/v2\/comments?post=6765"}],"version-history":[{"count":31,"href":"https:\/\/pancreasvlaanderen.be\/index.php\/wp-json\/wp\/v2\/pages\/6765\/revisions"}],"predecessor-version":[{"id":6811,"href":"https:\/\/pancreasvlaanderen.be\/index.php\/wp-json\/wp\/v2\/pages\/6765\/revisions\/6811"}],"wp:attachment":[{"href":"https:\/\/pancreasvlaanderen.be\/index.php\/wp-json\/wp\/v2\/media?parent=6765"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}